SEC Form 4 · accession 0001415889-18-001204
CELGENE CORP /DE/ · CELG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nadim Ahmed
Officer — PRES., HEMATOLOGY AND ONCOLOGY
Period of report
Jul 30, 2018
Accepted (ET)
Aug 1, 2018 · 4:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000816284
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2,F1 | $88.91 | Jul 30, 2018 | A | 10,548 | A | — | Jul 30, 2028 | Common Stock | 10,548 | 10,548 | D |
Explanation of responses
- F1Option is immediately exercisable and will vest in four equal annual installments commencing on July 30, 2019.
- F2The option was issued pursuant to the Company's 2017 Stock Incentive Plan.